A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
Koen van Rossem
◽
Jenny Lowe
2017 ◽
Vol 57
(6)
◽
pp. 751-759
◽
Carlos R. Becerra
◽
Kenichiro Yoshida
◽
Hirokazu Mizuguchi
◽
Manish Patel
◽
Daniel Von Hoff
2011 ◽
Vol 33
(1)
◽
pp. 146-157
◽
David John Critchley
◽
Jagadeesh Aluri
◽
Peter Boyd
◽
Matthew Whayman
◽
Milind Narurkar
◽
...
2020 ◽
Vol 37
(6)
◽
pp. 2696-2709
Lu Wang
◽
Yujing Di
◽
Tingting Guo
◽
Jeffrey E. Ming
◽
Fangyuan Kong
◽
...
Justin T. Hoffman
◽
Melissa O'Gorman
◽
Cho-Ming Loi
◽
Anna Plotka
◽
Tanya Boutros
◽
...
Justin T. Hoffman
◽
Anna Plotka
◽
Melissa O'Gorman
◽
Cho-Ming Loi
◽
Leonid Kirkovsky
◽
...
David W. Armstrong
◽
William Wargin
◽
David Mottola
◽
Eugene J. Sullivan
2005 ◽
Vol 66
(2)
◽
pp. 69-79
◽
Kuo-Liong Chien
◽
Chia-Lun Chao
◽
Ta-Cheng Su
2019 ◽
Vol 38
(1)
◽
pp. 131-139
◽
Maulik Patel
◽
Joseph Chen
◽
Stephanie McGrory
◽
Melissa O’Gorman
◽
Sunil Nepal
◽
...
2020 ◽
Vol 9
(8)
◽
pp. 972-977
◽
Mark Johnson
◽
Roxanne C. Jewell
◽
Jianjun Gan
◽
Etienne Dumont
◽
Olivia Burns
◽
...
Close
Export Citation Format
Close
Share Document
Close